Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Benesch

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Human Reproduction (Oxford, England)|August 8, 2023
Rhabdoid tumors in patients conceived following ART: is there an association?Karolina Nemes, Martin Benesch, Julia Kolarova, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2020
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)Karolina Nemes, Susanne Bens, Denis Kachanov, et al.
Acta Neuropathologica Communications|November 19, 2024
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotypeArnault Tauziède-Espariat, Lea L Friker, Gunther Nussbaumer, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Journal of Neuro-Oncology|February 22, 2022
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Martin Mynarek, Christian Hagel, et al.
Neuro-Oncology|December 25, 2016
Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start dataMartin Mynarek, Barry Pizer, Christelle Dufour, et al.
Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Human Reproduction (Oxford, England)|August 8, 2023
Rhabdoid tumors in patients conceived following ART: is there an association?Karolina Nemes, Martin Benesch, Julia Kolarova, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2020
Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)Karolina Nemes, Susanne Bens, Denis Kachanov, et al.
Acta Neuropathologica Communications|November 19, 2024
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotypeArnault Tauziède-Espariat, Lea L Friker, Gunther Nussbaumer, et al.
Pageof 16